Arteris (NASDAQ:AIP) Trading Up 7.9% Following Analyst Upgrade

Shares of Arteris, Inc. (NASDAQ:AIP) were up 7.9% on Thursday after TD Cowen raised their price target on the stock from $22.00 to $40.00. TD Cowen currently has a buy rating on the stock. Arteris traded as high as $37.99 and last traded at $38.3510. Approximately 431,271 shares were traded during mid-day trading, a decline of 25% from the average daily volume of 575,305 shares. The stock had previously closed at $35.55.

Several other research analysts also recently commented on the company. Jefferies Financial Group raised their price objective on Arteris from $16.00 to $35.00 and gave the stock a “hold” rating in a research note on Wednesday. Northland Securities set a $24.00 price objective on Arteris in a research note on Friday, February 13th. Rosenblatt Securities raised their price objective on Arteris from $20.00 to $38.00 and gave the stock a “buy” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research note on Monday, April 20th. Finally, Wall Street Zen downgraded Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Two analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $37.75.

Insider Transactions at Arteris

In related news, major shareholder Bayview Legacy, Llc sold 70,000 shares of the firm’s stock in a transaction on Wednesday, April 8th. The stock was sold at an average price of $19.04, for a total value of $1,332,800.00. Following the completion of the sale, the insider directly owned 9,119,071 shares in the company, valued at $173,627,111.84. This trade represents a 0.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO K Charles Janac sold 70,000 shares of the firm’s stock in a transaction on Wednesday, April 8th. The stock was sold at an average price of $19.04, for a total value of $1,332,800.00. Following the completion of the sale, the chief executive officer owned 9,119,071 shares of the company’s stock, valued at approximately $173,627,111.84. This represents a 0.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 866,923 shares of company stock worth $18,543,293. 29.10% of the stock is currently owned by company insiders.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris delivered a smaller-than-expected Q1 loss of $0.03 per share, beating estimates and improving from a $0.09 loss a year ago, which supports the recent stock strength. Article Title
• Positive Sentiment: Revenue of $22.94 million topped expectations, reinforcing confidence that demand and execution are improving. Article Title
• Positive Sentiment: Management raised second-quarter and full-year 2026 revenue guidance, signaling that momentum may continue into the rest of the year. Article Title
• Positive Sentiment: Rosenblatt Securities sharply raised its price target from $20 to $38 and reiterated a Buy rating, adding to the bullish sentiment around the stock. Article Title
• Neutral Sentiment: Arteris also released its earnings call transcript and presentation, which may provide more detail on growth drivers and profitability progress. Article Title
• Neutral Sentiment: The company disclosed a new shareholder-rights risk item, which adds a cautionary note but appears secondary to the strong earnings story. Article Title
• Negative Sentiment: Insider and major shareholder Bayview Legacy, LLC sold 70,000 shares, a potential overhang even though the sale was modest relative to its remaining stake. Article Title

Institutional Trading of Arteris

A number of institutional investors have recently bought and sold shares of AIP. Roubaix Capital LLC bought a new stake in shares of Arteris during the 3rd quarter worth approximately $2,361,000. Granahan Investment Management LLC lifted its stake in shares of Arteris by 725.7% during the 3rd quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after acquiring an additional 546,341 shares during the last quarter. Herald Investment Management Ltd lifted its stake in shares of Arteris by 33.3% during the 3rd quarter. Herald Investment Management Ltd now owns 400,000 shares of the company’s stock worth $4,036,000 after acquiring an additional 100,000 shares during the last quarter. GSA Capital Partners LLP lifted its stake in shares of Arteris by 59.3% during the 3rd quarter. GSA Capital Partners LLP now owns 132,079 shares of the company’s stock worth $1,334,000 after acquiring an additional 49,153 shares during the last quarter. Finally, Huntleigh Advisors Inc. bought a new stake in shares of Arteris during the 4th quarter worth approximately $1,832,000. 64.36% of the stock is currently owned by institutional investors.

Arteris Trading Up 7.0%

The stock has a 50-day simple moving average of $20.74 and a two-hundred day simple moving average of $17.31. The firm has a market capitalization of $1.75 billion, a P/E ratio of -48.22 and a beta of 1.93.

Arteris (NASDAQ:AIP) last issued its earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million for the quarter, compared to the consensus estimate of $21.03 million. As a group, research analysts expect that Arteris, Inc. will post -0.68 EPS for the current year.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.